Endotronix Overview
- Year Founded
-
2007
- Status
-
Acquired/Merged
- Employees
-
153
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$675M
- Investors
-
1
Endotronix General Information
Description
Developer of proactive heart management tools designed to detect cardiac failure. The company's tools offer a patient management platform and a pulmonary artery pressure sensor that connects patients, clinicians, and reimbursement teams through streamlined patient management driving meaningful clinical and economic outcomes, enabling health professionals to help patients detect worsening heart failure at home.
Contact Information
Website
www.endotronix.com(Operating Subsidiary)
Corporate Office
- 1415 West Diehl Road
- Suite 500W
- Naperville, IL 60563
- United States
Corporate Office
- 1415 West Diehl Road
- Suite 500W
- Naperville, IL 60563
- United States
Endotronix Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 15. Merger/Acquisition | 24-Jul-2024 | $675M | Completed | Generating Revenue | ||
| 14. Debt - PPP | 11-Apr-2020 | Completed | Generating Revenue | |||
| 13. Later Stage VC (Series D) | 24-Sep-2019 | Completed | Generating Revenue | |||
| 12. Accelerator/Incubator | 01-Jun-2018 | Completed | Generating Revenue | |||
| 11. Later Stage VC (Series C) | 12-Feb-2018 | Completed | Generating Revenue | |||
| 10. Later Stage VC (Series AA) | 06-Nov-2017 | Completed | Generating Revenue | |||
| 9. Debt - General | 09-Jan-2017 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series B) | 29-Apr-2014 | Completed | Generating Revenue | |||
| 7. Angel (individual) | 01-May-2013 | $1.5M | $8.36M | Completed | Generating Revenue | |
| 6. Angel (individual) | 01-May-2012 | $1.8M | $6.86M | Completed | Generating Revenue |
Endotronix Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D | ||||||||
| Series D Voting | ||||||||
| Series C Voting | ||||||||
| Series C | ||||||||
| Series B | 17,631,414 | $0.000010 | 5% | $0.58 | $0.58 | 1x | $0.58 | 5.2% |
| Series A | 7,707,622 | $0.000010 | 5% | $0.52 | $0.52 | 1x | $0.52 | 2.28% |
Endotronix Comparisons
Industry
Financing
Details
Endotronix Competitors (8)
One of Endotronix’s 8 competitors is Wellframe, a Private Equity-Backed company based in Boston, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Wellframe | Private Equity-Backed | Boston, MA | ||||
| ZeOmega | Venture Capital-Backed | Plano, TX | ||||
| Lightbeam Health Solutions | Venture Capital-Backed | Dallas, TX | ||||
| Fire1 | Venture Capital-Backed | Dublin, Ireland | ||||
| VirtualHealth | Venture Capital-Backed | Tampa, FL |
Endotronix Patents
Endotronix Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20220211282-A1 | Hemodynamic monitoring system and method and harness for same | Pending | 06-Jan-2021 | ||
| AU-2022206249-A1 | Hemodynamic monitoring system and method and harness for same | Pending | 06-Jan-2021 | ||
| CA-3207149-A1 | Hemodynamic monitoring system and method and harness for same | Pending | 06-Jan-2021 | ||
| EP-4274473-A1 | Hemodynamic monitoring system and method and harness for same | Pending | 06-Jan-2021 | ||
| AU-2019416137-A1 | Sensor delivery system and method | Pending | 26-Dec-2018 | A61B5/0215 |
Endotronix Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Endotronix Former Investors (21)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Aperture Venture Partners | Venture Capital | Minority | ||
| BV Capital Partners | PE/Buyout | Minority | ||
| BioVentures Investors | Venture Capital | Minority | ||
| Central Illinois Angels | Angel Group | Minority | ||
| Cornerstone Angels | Angel Group | Minority |
Endotronix Acquisitions (1)
Endotronix’s most recent deal was a Merger/Acquisition with Vital Sensors. The deal was made on 01-May-2020.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Vital Sensors | 01-May-2020 | Merger/Acquisition | Monitoring Equipment |
Endotronix FAQs
-
When was Endotronix founded?
Endotronix was founded in 2007.
-
Where is Endotronix headquartered?
Endotronix is headquartered in Naperville, IL.
-
What is the size of Endotronix?
Endotronix has 153 total employees.
-
What industry is Endotronix in?
Endotronix’s primary industry is Enterprise Systems (Healthcare).
-
Is Endotronix a private or public company?
Endotronix is a Private company.
-
What is the current valuation of Endotronix?
The current valuation of Endotronix is .
-
What is Endotronix’s current revenue?
The current revenue for Endotronix is .
-
How much funding has Endotronix raised over time?
Endotronix has raised $135M.
-
Who are Endotronix’s investors?
Aperture Venture Partners, BV Capital Partners, BioVentures Investors, Central Illinois Angels, and Cornerstone Angels are 5 of 21 investors who have invested in Endotronix.
-
Who are Endotronix’s competitors?
Wellframe, ZeOmega, Lightbeam Health Solutions, Fire1, and VirtualHealth are some of the 8 competitors of Endotronix.
-
When was Endotronix acquired?
Endotronix was acquired on 24-Jul-2024.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
